Concepedia

3D in vitro Model of Vascular Medial Thickening in Pulmonary Arterial Hypertension

Chiharu Morii, Hiroyoshi Tanaka, Yasuhisa Izushi, Natsumi Nakao, Masaya Yamamoto, Hiromi Matsubara, Mitsunobu R. Kano, Aiko Ogawa

Frontiers in Bioengineering and Biotechnology · 2020 · 16 citations · 20 references

DOIFull text

Open access

Concepts

Abstract

. This model is potentially useful for assessing the ability of candidate PAH drugs to suppress medial thickening.

References

20

Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

Marc Humbert, Olivier Sitbon, Ari Chaouat et al. · Circulation · 2010 · 1.4K citations

, , +12

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Raymond L. Benza, Dave P. Miller, Robyn J. Barst et al. · CHEST Journal · 2012 · 1.1K citations

, , +7

Reversal of experimental pulmonary hypertension by PDGF inhibition

Ralph T. Schermuly · Journal of Clinical Investigation · 2005 · 1.1K citations · Full text

, , +16

Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

Marius M. Hoeper, Robyn J. Barst, Robert C. Bourge et al. · Circulation · 2013 · 562 citations

, , +13

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

Martin H. Cohen, Grant Williams, John R. Johnson et al. · PubMed · 2002 · 469 citations

, , +13